General Archive
-
ArticlesTranslational research into children’s rare diseases enters 5th year of collaborative funding
Accelerating research that will have a significant impact on the treatment of children and young people
-
ArticlesTalking to FLIER future leaders about learning from COVID-19 and the power of collaboration
The Future Leaders in Innovation Enterprise and Research is a two-year programme for emerging leaders in science, technology and medicine.
-
ArticlesHighlights from Illumina for Startups Summit 2023
Key takeaways from the summit for entrepreneurs, founders, investors and industry leaders from around the world.
-
ArticlesInternational Women’s Day 2023
Tips on career advancement, from some of LifeArc’s incredible women
-
ArticlesHonouring the contribution of a remarkable trustee – Aisling Burnand CBE
Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.
-
ArticlesRare Disease Day 2023 – Robbie’s story
Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.
-
ArticlesFour ways we support rare disease research
LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.
-
ArticlesLifeArc awards £3 million to advance promising early rare disease research from the lab to the patient
Pump-prime funding to help researchers get innovative approaches off the ground
-
ArticlesCelebrating the International Day of Women and Girls in Science
LifeArc celebrates this year’s UN Day for Women and Girls in STEM.
-
ArticlesAlzheimer’s drug lecanemab approved by US regulator
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…
-
Articles2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
ArticlesMND Collaborative Partnership cautiously welcomes new Government funding
We cautiously welcome the Government’s announcement on how their £50m commitment into MND research will be spent.